Evidence map›Paper›PMID 27822177›Full record

ArticleTobacco induced diseases2016

Smoking cessation attempts: is it useful to treat hard core smokers?

B Joly, P D'Athis, L Gerbaud, J Hazart, J Perriot, C Quantin

Abstract read
In one paragraph

Article in Tobacco induced diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

B JolyService de Biostatistique et d'Informatique Médicale (DIM), CHRU Dijon, Dijon, F-21000 France.
P D'AthisService de Biostatistique et d'Informatique Médicale (DIM), CHRU Dijon, Dijon, F-21000 France.
L GerbaudService de santé Publique, CHU Clermont-Ferrand, EA PEPRADE4681 Université d'Auvergne, Clermont-Ferrand, France.
J HazartService de santé Publique, CHU Clermont-Ferrand, EA PEPRADE4681 Université d'Auvergne, Clermont-Ferrand, France.
J PerriotDispensaire Emile Roux, Centre d'Aide à I'Arrêt du Tabagisme (IRAAT), Centre de Lutte Anti-Tuberculeuse (CLAT), 63100 Clermont-Ferrand, France.
C QuantinService de Biostatistique et d'Informatique Médicale (DIM), CHRU Dijon, Dijon, F-21000 France ; INSERM, CIC 1432, Dijon, France; Dijon University Hospital, Clinical Investigation Center, Clinical epidemiology/clinical trials unit, Dijon, France ; Inserm UMR 1181 « Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases » (B2PHI), Univ. Bourgogne Franche-Comté, F-21000 Dijon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHard core smokers have been studied in many countries but only a few trials have compared the effectiveness of smoking cessation with other smokers. The objective of this study was to compare the frequencies of success in smoking cessation between hard-core smokers and other smokers.

methodsData were collected in Clermont-Ferrand from the Emile Roux dispensary 'Pneumology and Tobaccology Centre' between 1999 and 2009. Assistance with smoking cessation was proposed to 1367 patients but only 1296 patients were included: 219 HCS and 1077 other smokers. Smoking cessation was considered a success when patients were abstinent 6 months after the beginning of cessation. The profiles of the two types of smokers were compared using Chi square test and Student's t test. Multivariate logistic regression was used to investigate the association between the smoking cessation result and the type of smokers.

resultsHCS more frequently consumed other psychoactive substances (41.1 % vs 25.7 % for other smokers;

conclusionSmoking cessation is possible for hard core smokers, who should be treated as other types of smokers taking into account other factors:the problem is how to encourage them to try to stop smoking.

Indexed as

Cigarette consumptionHard coreQuit attemptSmoking cessation

Identifiers

PMID27822177
PMCPMC5093930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.